advertisement
Tsuda S 23
Showing records 1 to 23 | Display all abstracts from Tsuda S86417 A pyruvate dehydrogenase kinase inhibitor prevents retinal cell death and improves energy metabolism in rat retinas after ischemia/reperfusion injury
Sato K
Experimental Eye Research 2020; 193: 107997
86141 The optic nerve head vasoreactive response to systemic hyperoxia and visual field defect progression in open-angle glaucoma, a pilot study
Kiyota N
Acta Ophthalmologica 2020; 98: e747-e753
86341 Structural Characterization of Glaucoma Patients with Low Ocular Blood Flow
Omodaka K; Fujioka S
Current Eye Research 2020; 45: 1302-1308
86141 The optic nerve head vasoreactive response to systemic hyperoxia and visual field defect progression in open-angle glaucoma, a pilot study
Shiga Y
Acta Ophthalmologica 2020; 98: e747-e753
86417 A pyruvate dehydrogenase kinase inhibitor prevents retinal cell death and improves energy metabolism in rat retinas after ischemia/reperfusion injury
Mochida S
Experimental Eye Research 2020; 193: 107997
86141 The optic nerve head vasoreactive response to systemic hyperoxia and visual field defect progression in open-angle glaucoma, a pilot study
Yasuda M
Acta Ophthalmologica 2020; 98: e747-e753
86341 Structural Characterization of Glaucoma Patients with Low Ocular Blood Flow
An G
Current Eye Research 2020; 45: 1302-1308
86417 A pyruvate dehydrogenase kinase inhibitor prevents retinal cell death and improves energy metabolism in rat retinas after ischemia/reperfusion injury
Tomimoto D; Konuma T
Experimental Eye Research 2020; 193: 107997
86341 Structural Characterization of Glaucoma Patients with Low Ocular Blood Flow
Udagawa T
Current Eye Research 2020; 45: 1302-1308
86141 The optic nerve head vasoreactive response to systemic hyperoxia and visual field defect progression in open-angle glaucoma, a pilot study
Aizawa N
Acta Ophthalmologica 2020; 98: e747-e753
86417 A pyruvate dehydrogenase kinase inhibitor prevents retinal cell death and improves energy metabolism in rat retinas after ischemia/reperfusion injury
Kiyota N
Experimental Eye Research 2020; 193: 107997
86341 Structural Characterization of Glaucoma Patients with Low Ocular Blood Flow
Tsuda S
Current Eye Research 2020; 45: 1302-1308
86141 The optic nerve head vasoreactive response to systemic hyperoxia and visual field defect progression in open-angle glaucoma, a pilot study
Omodaka K
Acta Ophthalmologica 2020; 98: e747-e753
86417 A pyruvate dehydrogenase kinase inhibitor prevents retinal cell death and improves energy metabolism in rat retinas after ischemia/reperfusion injury
Tsuda S
Experimental Eye Research 2020; 193: 107997
86341 Structural Characterization of Glaucoma Patients with Low Ocular Blood Flow
Shiga Y
Current Eye Research 2020; 45: 1302-1308
86141 The optic nerve head vasoreactive response to systemic hyperoxia and visual field defect progression in open-angle glaucoma, a pilot study
Tsuda S; Pak K
Acta Ophthalmologica 2020; 98: e747-e753
86341 Structural Characterization of Glaucoma Patients with Low Ocular Blood Flow
Morishita S
Current Eye Research 2020; 45: 1302-1308
86417 A pyruvate dehydrogenase kinase inhibitor prevents retinal cell death and improves energy metabolism in rat retinas after ischemia/reperfusion injury
Shiga Y
Experimental Eye Research 2020; 193: 107997
86141 The optic nerve head vasoreactive response to systemic hyperoxia and visual field defect progression in open-angle glaucoma, a pilot study
Kunikata H
Acta Ophthalmologica 2020; 98: e747-e753
86341 Structural Characterization of Glaucoma Patients with Low Ocular Blood Flow
Kikawa T
Current Eye Research 2020; 45: 1302-1308
86417 A pyruvate dehydrogenase kinase inhibitor prevents retinal cell death and improves energy metabolism in rat retinas after ischemia/reperfusion injury
Omodaka K; Nakazawa T
Experimental Eye Research 2020; 193: 107997
86141 The optic nerve head vasoreactive response to systemic hyperoxia and visual field defect progression in open-angle glaucoma, a pilot study
Nakazawa T
Acta Ophthalmologica 2020; 98: e747-e753
86341 Structural Characterization of Glaucoma Patients with Low Ocular Blood Flow
Pak K; Akiba M; Yokota H; Nakazawa T
Current Eye Research 2020; 45: 1302-1308
